...

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >THE COMPARISONS OF BIOLOGICS WITH METHOTREXATE FOR TREATING RHEUMATOID ARTHRITIS PATIENTS IN TAIWAN: THE USE OF COST-UTILITY ANALYSIS AND BUDGET IMPACT ANALYSIS

【24h】

THE COMPARISONS OF BIOLOGICS WITH METHOTREXATE FOR TREATING RHEUMATOID ARTHRITIS PATIENTS IN TAIWAN: THE USE OF COST-UTILITY ANALYSIS AND BUDGET IMPACT ANALYSIS

机译：生物制剂与甲氨蝶呤治疗台湾类风湿关节炎患者的比较：成本效用分析和预算影响分析的使用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第7期|共1页
作者
Li C.; Chou P.; Chang C.; Fann C. S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. THE COMPARISONS OF BIOLOGICS WITH METHOTREXATE FOR TREATING RHEUMATOID ARTHRITIS PATIENTS IN TAIWAN: THE USE OF COST-UTILITY ANALYSIS AND BUDGET IMPACT ANALYSIS [J] . Li C., Chou P., Chang C., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：生物制剂与甲氨蝶呤治疗台湾类风湿关节炎患者的比较：成本效用分析和预算影响分析的使用
2. No impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs: a systematic literature review and meta-analysis [J] . Adeline Ruyssen-Witrand, Alain Cantagrel, Arnaud Constantin, RMD Open . 2017,第1期

机译：联合使用甲氨蝶呤对bDMARDs治疗的类风湿关节炎患者的严重不良事件和严重感染风险没有影响：系统的文献综述和荟萃分析
3. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial [J] . Goss Sandra L., Klein Cheri E., Jin Ziyi, Clinical therapeutics . 2018,第2期

机译：早期类风湿性关节炎患者的甲氨蝶呤剂量会影响甲氨蝶呤聚谷氨酸药代动力学，Adalimalab药代动力学和疗效：协调审判的药代动力学和曝光 - 反应分析
4. Instrumentation for the analysis of changes in the knee joint of patients with rheumatoid arthritis: focus on low-frequency vibrations [C] . A C D Faria, G R C Pinheiro, J Neri, Joint IMEKO TC1-TC7-TC13 Symposium: Measurement Science Challenges in Natural and Social Sciences . 2017

机译：类风湿性关节炎患者膝关节变化分析的仪表：重点是低频振动
5. Impact of Ultrasonography on Use of Biologics in Patients with Rheumatoid Arthritis [D] . Atzinger, Christopher B. 2018

机译：超声检查对类风湿关节炎患者使用生物制剂的影响
6. Original article: No impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs: a systematic literature review and meta-analysis [O] . Claire Baradat, Yannick Degboé, Arnaud Constantin, 2017

机译：原始文章：甲氨蝶呤的同时使用对使用bDMARDs治疗的类风湿关节炎患者的严重不良事件和严重感染风险没有影响：系统的文献综述和荟萃分析
7. PMS45 Cost-Utility and Budget Impact Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-to-Severe Active Rheumatoid Arthritis in Greece [O] . Maniadakis N., Boumpas D., Kourlaba G., 2011

机译：在希腊治疗中度至重度活动性类风湿关节炎的Certolizumab Pegol加甲氨蝶呤的PMS45成本效用和预算影响分析

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号